NETEC Webinar Series Presentation

Mpox in 2024: Updates and Considerations for Frontline Staff

The estimated time to complete this enduring material is 60 minutes.

TARGET AUDIENCE

This accredited continuing education activity is designed for frontline workers, laboratorians, physicians, nurses, and infection preventionists.

EDUCATIONAL OBJECTIVES

At the conclusion of this enduring material, the participant should be better able to:

• Discuss current landscape of Mpox both domestically and internationally.
• Explain the Mpox vaccine recommendations and available treatment options.
• Explain lab considerations for specimen collection and testing.
• Differentiate between categorization of waste.

REQUIREMENTS FOR SUCCESSFUL COMPLETION

In order to receive a certificate of completion, you must complete these steps.

1. View the entire presentation
2. Complete the post-test with a score of 2 out of 3 or better
3. Complete the online evaluation
4. Submit the Completion Attestation

FACULTY

Jonathan Grein, MD
Off-label Disclosure: Tecovirimat for treatment of Mpox

The following faculty have nothing to disclose:

• Vicki Herrera, MS*
• John Horton, MD
• Kari Love, MS, RN, CIC, FAPIC
• Anna Yaffee, MD, MPH*

PLANNING COMMITTEE

The below planning committee members have nothing to disclose:

• Britton Clark, MPH, CNP
• Valeta Creason-Wahl, MMP
• Chimora Imonugo, MD, MPH
• Heidi Keeler, PhD, MSN/MBA, RN
• Benjamin Mattson, MS Ed
• Jason Noble, BA, BFA
• Aileen Patel, MS, RN, CCRN
• Renee Paulin, MSN, RN, CWOCN
• Brenda Ram, CMP, CHCP

FINANCIAL SUPPORT 

This program is funded by ASPR